A Day Up For Summit Therapeutics plc
Mon, May 17, 2021 at 05:30 PM
Summit Therapeutics plc (SMMT:NASDAQ) shot up at $6.85, a gain of 26.6%. On Fri, May 14, 2021, SMMT:NASDAQ hit a New 2-Week Low of $5.41. The stock got featured on our News Catalysts scanner on Mon, May 17, 2021 at 09:16 AM in the 'EARNINGS' category. From Fri, Apr 30, 2021, the stock recorded 20.00% Up Days and 18.18% Green Days
The share price of the company has been moving sideways in recent weeks.
About Summit Therapeutics plc (SMMT:NASDAQ)
Summit Therapeutics PLC is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies.
Top 10 Gainers:
- Sanchez Midstream Partners LP (SNMP:NYSEMKT), 53.52%
- Pintec Technology Holdings Limited (PT:NASDAQ), 48.75%
- Peabody Energy Corporation (BTU:NYSE), 32.31%
- NVVE (NVVE:NASDAQ), 30.91%
- Foresight Autonomous Holdings Ltd. (FRSX:NASDAQ), 28.32%
- Summit Therapeutics plc (SMMT:NASDAQ), 26.62%
- Western Copper and Gold Corporation (WRN:NYSEMKT), 26.22%
- Iteris, Inc. (ITI:NASDAQ), 24.71%
- IZEA Worldwide, Inc. (IZEA:NASDAQ), 24.12%
- U.S. Well Services, Inc. (USWS:NASDAQ), 22.59%